Adage Capital Partners
NVAX icon

Adage Capital Partners’s Novavax NVAX Stock Holding History

Adage Capital Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300,000
Closed -$2.23M – 914
2023
Q2 		$2.23M Buy
+300,000
New +$2.36M ﹤0.01% 738
2021
Q4 		– Sell
-10,000
Closed -$2.07M – 1078
2021
Q3 		$2.07M Buy
+10,000
New +$2.2M ﹤0.01% 893
2021
Q1 		– Sell
-403,283
Closed -$45M – 1000
2020
Q4 		$45M Buy
403,283
+378,283
+1,513% +$40.2M 0.1% 223
2020
Q3 		$2.71M Sell
25,000
-174,600
-87% -$21.3M 0.01% 692
2020
Q2 		$16.6M Buy
+199,600
New +$7.63M 0.04% 427

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Adage Capital Partners's NVAX Position: Q3 2023 in Review

Adage Capital Partners sold out of Novavax (NVAX) in Q3 2023, closing a stake of 300,000 shares — an estimated $2.23M sold.

Adage Capital Partners first reported a position in NVAX in Q2 2020 and held it in 5 quarters. The position peaked at $45M in Q4 2020. 225 funds tracked by Wall St. Rank hold NVAX as of Q3 2023.

  • Adage Capital Partners reported no remaining Novavax position as of Q3 2023 after selling out during the quarter.
  • Adage Capital Partners sold 300,000 Novavax shares in Q3 2023, an estimated $2.23M.
  • Adage Capital Partners first reported a position in Novavax in Q2 2020 and held it in 5 quarters.
  • Adage Capital Partners's Novavax position peaked at $45M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held Novavax as of Q3 2023.

Based on Adage Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.